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RESEARCH ARTICLE
Lipophilic fractions from the marine sponge Halichondria sitiens decrease secretion
of pro-inflammatory cytokines by dendritic cells and decrease their ability to
induce a Th1 type response by allogeneic CD4þ T cells
Xiaxia Dia,b, Jon T. Oskarssonb,c,d, Sesselja Omarsdottira, Jona Freysdottirb,c,d† and Ingibjorg Hardardottirb,d†
aFaculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland; bDepartment of Immunology, Landspitali – The National University
Hospital of Iceland, Reykjavik, Iceland; cCentre for Rheumatology Research, Landspitali – The National University Hospital of Iceland, Reykjavik,
Iceland; dFaculty of Medicine, Biomedical Center, University of Iceland, Reykjavik, Iceland
ABSTRACT
Context: Halichondria (Halichondriidae) marine sponges contain components possessing various biological
activities, but immunomodulation is not among the ones reported.
Objective: This study evaluated the immunomodulatory effects of fractions/compounds from Halichondria
sitiens Schmidt.
Materials and methods: Crude dichloromethane/methanol extracts of H. sitiens were subjected to various
chromatographic techniques to obtain fractions/compounds with immunomodulatory activity, using bio-
assay-guided isolation. The effects of the fractions/compounds were determined by measuring secretion
of cytokines and expression of surface molecules by dendritic cells (DCs) and their ability to stimulate and
modify cytokine secretion by allogeneic CD4þ T cells. The bioactive fractions were chemically analyzed to
identify the immunomodulatory constituents by 1D, 2D NMR, and HRMS data.
Results: Several lipophilic fractions from H. sitiens at 10lg/mL decreased secretion of the pro-inflamma-
tory cytokines IL-12p40 and IL-6 by the DCs, with maximum inhibition being 64% and 25%, respectively.
In addition, fractions B3b3F and B3b3J decreased the ability of DCs to induce T cell secretion of IFN-c.
Fraction B3b3 induced morphological changes in DCs, characterized by extreme elongation of dendrites
and cell clustering. Chemical screening revealed the presence of glycerides and some minor unknown
constituents in the biologically active fractions. One new glyceride, 2,3-dihydroxypropyl 2-methylhexadeca-
noate (1), was isolated from one fraction and two known compounds, 3-[(1-methoxyhexadecyl)oxy]pro-
pane-1,2-diol (2) and monoheptadecanoin (3), were identified in another, but none of them had
immunomodulatory activity.
Discussion and conclusions: These results demonstrate that several lipophilic fractions from
H. sitiens have anti-inflammatory effects on DCs and decrease their ability to induce a Th1 type immune
response.
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Introduction
Over the last decades, there has been an increasing interest in
investigating organisms of marine origin for potential drug leads
(Tulp and Bohlin 2004; Cragg and Newman 2013). The ocean is
the largest ecosystem on earth with immense biological diversity
and it is considered an underutilized biological resource of new
and diverse chemical entities with great potential for biomedical
applications (Cragg and Newman 2013). Environmental condi-
tions, such as temperature, salinity, pressure, light exposure, con-
tent of halogens and water quality, vary within the marine world
and are markedly different from that of terrestrial environments.
These environmental conditions have given marine organisms
capacity to produce unique compounds with distinct metabolic
and ecological roles.
Marine sponges are found to be a valuable source of bioactive
metabolites that are important for their chemical defence against
predators, space competitors and fouling (Mehbub et al. 2014).
Bioactive extracts/compounds from marine sponges have been
reported to have a wide range of activities, including anti-inflam-
matory, antioxidant, antiviral and antibacterial activities (Proksch
et al. 2010; Joseph and Sujatha 2011).
Marine sponges of the genus Halichondria Fleming, 1828
(Halichondriidae) have been reported to contain various fatty
acids (Imbs and Rodkina 2004), glycolipids (Nagle et al. 1992; Li
et al. 1995), sterols (Jin et al. 2006), alkaloids (Tsubosaka et al.
2010) and terpenoids (Ishiyama et al. 2008). Some of these com-
pounds possess antibacterial, cytotoxic, antifungal and antimicro-
bial properties (Jin et al. 2006). Although several recent studies
have discovered anti-inflammatory activity of marine sponge-
derived extracts (Costantini et al. 2015; Cheung et al. 2016), no
studies have reported anti-inflammatory activities in extracts or
fractions from Halichondria (Eumastia) sitiens (Schmidt, 1870),
the sponge analyzed in the present study.
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Inflammation is the response of the immune system against
infection and tissue injury. Dendritic cells (DCs) play an import-
ant role in initiating a powerful adaptive immune response by
activating naïve T cells (Banchereau and Steinman 1998). DCs
further polarize the adaptive immune responses by their cytokine
secretion, inducing appropriate T helper (Th) responses by
directing the differentiation of naïve T cells into different Th
effector cells, such as Th1, Th2 and Th17 (Kaiko et al. 2008).
Th1 and Th17 cells are the main types of T cells participating in
chronic immune responses; thus, the ability to dampen the
responses of these cells may be beneficial to patients suffering
from chronic inflammatory diseases.
In this study, the potential immunomodulatory activity of
fractions/compounds from H. sitiens was explored by investigat-
ing their effects on maturation and activation of human mono-
cyte-derived DCs and on the ability of the treated DCs to
stimulate and differentiate allogeneic CD4þ T cells. Bioassay-
guided isolation of the crude extract yielded 11 bioactive
fractions with anti-inflammatory effects on DCs and selected
fractions decreased the ability of the DCs to induce a Th1 type
immune response. In addition, several of the biologically active
fractions induced morphological changes in the DCs.
Materials and methods
Collection and identification of the marine sponge
H. sitiens was collected in July 2015 by scuba diving from the
rocks of Kolbeinsey, north of Iceland, at a depth of approxi-
mately 10m. The sponge was identified by Dr Hans Tore Rapp,
University of Bergen. A voucher specimen is deposited at the
Department of Natural Products Chemistry, Faculty of
Pharmaceutical Sciences, University of Iceland.
Extraction and bioassay-guided fractionation
The sponge was freeze-dried and then extracted twice with
CH2Cl2:CH3OH (1:1) and evaporated to dryness on a rotary vac-
uum evaporator at 30 C. The extract (105.3 g) was fractionated
into five fractions using solvent partitioning method (a modified
Kupchan method), starting with hexane (fraction A, 55.3 g), fol-
lowed by chloroform (fraction B, 13.0 g) and dichloromethane
(DCM) (fraction C, 0.4 g), n-butanol (fraction D, 3.4 g) and water
(fraction E, 24.5 g). The B fraction (4.0 g) showed immunomodu-
latory activity and was subjected to SPE Silica gel CC (DCM-
MeOH, 100:0!0:100) to obtain eight fractions (B1–B8). Fraction
B3 (423.8mg) was separated by Sephadex LH-20CC (MeOH)
into four fractions (B3a–B3d) and then B3b was separated by
Sephadex LH-20CC (MeOH–H2O, 90:10) to obtain four fractions
(B3b1–B3b4). Fraction B3b3 (125.8mg) was separated by pre-
parative HPLC (MeOH–H2O, 10:90!0:100, 4.0mL/min) with a
5 lm Agilent Eclipse XD8-C8 column (250mm 9.4mm, Agilent
Technologies, Inc., Santa Clara, CA) to obtain eighteen fractions
(B3b3A–B3b3R). The following fractions with immunomodula-
tory activity were selected for further studies: B3b3F (1.5mg,
tR¼ 18.92min), B3b3G (2.0mg, tR¼ 19.66min), B3b3H (1.2mg,
tR¼ 20.71min), B3b3I (1.5mg, tR¼ 23.63min), B3b3J (1.4mg,
tR¼ 24.27min), B3b3K (3.4mg, tR¼ 25.21min), B3b3L (2.7mg,
tR¼ 27.08min), B3b3M (3.8mg, tR¼ 27.25min), B3b3N (2.2mg,
tR¼ 28.05min), B3b3O (1.2mg, tR¼ 29.10min) and B3b3P
(1.1mg, tR¼ 32.12min). Fraction B3b3M was purified by HPLC
(acetonitrile–H2O, 85:15, 1mL/min) using YMC J'sphere ODS-
H80 (250mm 4.6mm, 8 nm, YMC Co., Ltd., Kyoto, Japan) and
one pure compound was obtained, i.e., 2,3-dihydroxypropyl 2-
methylhexadecanoate (1) (0.9mg, tR¼ 18.59min).
The compound 2,3-dihydroxypropyl 2-methylhexadecanoate
(1) is white powder; [a]26 D -10 (c 1.0, MeOH); IR max cm
–1:
3442, 2921, 2851, 1728, 1628, 1467, 1384, 1111, 672; for 1H and
13C NMR data, see Table 1; HRESIMS m/z 367.2811 [MþNa]þ
(C20H40O4Na, 367.2819).
Chemical analysis of the active fractions
The NMR spectra were run on a Bruker AM-400 spectrometer
(Bruker Corporation, Billerica, MA) with TMS as internal stand-
ard in deuterated chloroform as a solvent, unless otherwise
stated, at 400.13 and 100.61MHz for 1H and 13C, respectively.
Chemical shifts were reported with reference to the respective
residual solvent peaks (dH 7.27 and dC 77.0 for CDCl3). High-
resolution mass spectra (HRMS) were carried out on micrOTOF-
Q mass spectrometer from Bruker Daltonics (Billerica, MA).
Maturation and activation of DCs
Peripheral blood mononuclear cells (PBMCs) were obtained by
density-gradient centrifugation of blood from healthy human
donors using Ficoll Histopaque (Sigma-Aldrich, St. Louis, MO).
CD14þ monocytes were isolated using CD14 Microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany). Their purity was
determined by flow cytometry to be>95%. DCs were obtained
by culturing CD14þ monocytes in 48-well culture plates (Nunc)
at a concentration of 5 105 cells/mL in RPMI medium (GibcoVR ,
Invitrogen, Carlsbad, CA) in the presence of 12.5 ng/mL of IL-4
and 25 ng/mL of GM-CSF (both from R&D Systems,
Minneapolis, MN) for 7 d, with fresh medium and cytokines
added at day 3. The DCs were matured and activated by cultur-
ing them in 48-well culture plates at 2.5 105 cells/mL for 24 h
with IL-1b at 10 ng/mL, TNF-a at 50 ng/mL (both from R&D
Systems, Minneapolis, MN) and lipopolysaccharide (LPS) at
500 ng/mL (Sigma-Aldrich, St. Louis, MO). Fractions/compounds
from H. sitiens were dissolved in dimethyl sulphoxide (DMSO)
and then diluted in medium and added to the DCs at the same
time as the cytokines and LPS. DCs were also cultured in the
presence of the same concentration of DMSO as in the cultures
with the H. sitiens fractions/compounds (0.005%; solvent con-
trol). After 24 h, the mature and activated DCs were harvested
and the effects of the fractions/compounds on DC maturation
and activation were determined by measuring cytokine concen-
tration in the culture medium by ELISA and the expression of
surface molecules by flow cytometry.
Table 1. 1H (400MHz) and 13C (100MHz) NMR spectroscopic data of compound
1 in CDCl3.
2,3-Dihydroxypropyl 2-methylhexadecanoate (1)
Carbon number dH (J in Hz) dC
1 3.70, dd (11.5, 4.5)
3.60, dd (11.5, 6.0)
63.3
2 3.93, quint (4.5) 70.3
3 4.22, dd (12.0, 4.5)
4.16, dd (12.0, 6.0)
65.1
4 177.5
5 2.48, sextet (6.0) 39.5
6 1.16, d (7.0) 17.1
7 1.66, m 33.8
8–18 1.24–1.41, m 27.2–31.9
19 1.30, m 22.7
20 0.87, t (6.5) 14.1
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Viability assessment and morphology of DCs
The viability of DCs cultured with or without fractions from H.
sitiens was assessed by Trypan blue staining. DCs were matured
and activated in the presence/absence of fractions at the concen-
tration of 10 lg/mL. Untreated and solvent (DMSO) treated DCs
served as controls. Morphology of the DCs was evaluated in
10magnification using Leica microscope.
Co-culture of DCs and allogeneic CD41 T cells
CD4þ T cells were obtained from PBMCs using CD4
Microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), fol-
lowing the same procedure as for the isolation of CD14þ
monocytes described above. The purity of the CD4þ T cells
was determined by flow cytometry to be>95%. DCs that had
been matured and activated with TNF-a, IL-1b and LPS in the
presence or absence of fractions at 10 mg/mL were co-cultured
at 2 105 cell/mL with allogeneic CD4þ T cells at 2 106 cells/
mL in 96-well round bottom culture plates for 6 d. The effects
of the fractions on the ability of the DCs to activate the CD4þ
T cells were determined by measuring cytokine concentrations
in the co-cultures by ELISA and expression of activation mole-
cules by flow cytometry.
Determination of cytokine concentration by ELISA
The concentrations of IL-12p40, IL-6 and IL-10 in culture
supernatants from DCs and of IFN-c, IL-17 and IL-10 in
supernatants from co-cultured DCs and allogeneic CD4þ T
cells were measured by sandwich ELISA using DuoSets from
R&D Systems according to the protocol from the manufac-
turer. The results are expressed as secretion index (SI), i.e.,
the cytokine concentration in supernatants from DCs cultured
with H. sitiens fractions or co-cultures of these DCs with allo-
geneic CD4þ T cells divided by the cytokine concentration in
supernatants of DCs cultured without H. sitiens fractions or
co-cultures of these DCs with allogeneic CD4þ T cells. Using
SI minimizes the effect of the variance in cytokine secretion
by DCs from different individuals.
Determination of surface molecule expression by flow
cytometry
Surface molecule expression of monocytes, DCs and CD4þ T
cells was determined by flow cytometry. Five 105 cells were
stained with fluorochrome-labelled antibodies against CD14
(freshly isolated monocytes or differentiated DCs), CD4 (freshly
isolated or activated and differentiated T cells), CD86 and HLA-
DR (matured and activated DCs) and CD54, CD49d and CD69
(activated and differentiated T cells) and analyzed by
FACScalibur (BD Bioscience, Franklin Lakes, NJ). The results are
expressed as % of positive cells as compared with cells stained
with isotype control antibodies and mean fluorescence intensity.
Statistical analysis
Data are presented as the mean valuesþ standard error of the
mean (SEM). As the data were not normally distributed,
Mann–Whitney U test was used to determine statistical differen-
ces between treatments (SigmaStat 3.1, Systat Software, San Jose,
CA) and differences between means considered statistically sig-
nificant if p< 0.05.
Results
Chemical analysis of fractions and structure elucidation of
the main constituents
Chemical analysis of fractions B3b3F-B3b3P from H. sitiens was
conducted using NMR and HR-ESI-MS. Chemical analysis of
four of them, i.e., fractions B3b3F, B3b3J, B3b3P and B3b3M, is
reported. These fractions were chosen because of their potent
bioactivity (B3b3F and B3b3J), and/or because they contained
major components as revealed by 1H NMR and mass spectra
(B3b3J and B3b3M), or in the case of B3b3P because it had
much less bioactivity than the other fractions. The small amount
of the fractions and difficulties with purification prevented fur-
ther isolation of pure compounds (except compound 1 reported
below). Therefore, all spectra were recorded for the fractions and
the structure of the major constituents determined.
HRESIMS of fraction B3b3J gave two of [MþNa]þ pseudo-
molecular ion peaks at m/z 369.2965 and 367.2811, suggesting a
mixture of homologous compounds consistent with the molecu-
lar formulae C20H42O4 and C20H40O4, respectively. Combined
analysis of the 1D and 2D NMR showed that fraction B3b3J con-
tained a previously described glycerol ester, i.e., 3-[(1-methoxy-
hexadecyl)oxy]propane-1,2-diol (2) (Magnusson and Haraldsson
2010), and a known glycerol ether, i.e., monoheptadecanoin (3)
(Qi et al. 2010) (Figure 1) in the ratio of 1:2 based on the signal
heights in the 1H NMR spectrum. These two known compounds
were identified by comparison with the published physical and
spectral data. B3b3J also contained a small portion of unknown
compounds.
Analysis of the 1H NMR data of fraction B3b3F revealed that
the main compounds in it were glycerides, similar to the com-
pounds detected in fraction B3b3J but with double bonds in the
fatty acid chains. It also contained a small portion of unknown
compounds. Because fraction B3b3F contained more than three
compounds, the structure could not be determined from 1H
NMR and HRESIMS.
From the 1H NMR spectrum for fraction B3b3P, it was deter-
mined that it contained glycerides similar to the monoheptadeca-
noin (3). Because the mass spectra showed a complex mixture,
the exact chain length of the fatty acids could not be confirmed.
Fraction B3b3P also contained minor compounds that could not
be identified because of the limited amount available.
A new glyceride, 2,3-dihydroxypropyl 2-methylhexadecanoate
(1), was detected and purified from fraction B3b3M. Compound
1 was isolated as a white amorphous solid. Its molecular formula
Figure 1. Chemical structures of the compounds isolated or identified from H.
sitiens fractions B3b3M (1) and B3b3J (2 and 3).
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was established on the basis of MS and NMR spectral analysis.
The HR-ESI-MS showed the [MþNa]þ peak at 367.2811, which
matched well with the expected molecular formula C20H40O4Na
(Dþ 1.3 ppm). The 1D and 2D NMR spectra (Table 1) showed
the presence of two terminal methyls, numerous methylenes, two
of which were oxygenated, two methines, one of which was oxy-
genated, and one ester group. The 1H–1H COSY spectrum
(Figure 2) revealed two partial structures: the first part was sug-
gested to be one 1-substituted glyceryl group (C1–C3), which is
also supported by the HMBC correlations (Figure 2); the second
unit was assigned as 2-methylhexadecanoyl group (C4–C20),
because of the remaining signal of the two terminal methyls, one
methine, and 13 methylenes. The presence of 2-methylhexadeca-
noyl group was identified by the HMBC correlations from Me-6
to C-4, C-5 and C-7. The connection of these two parts was
deduced by the HMBC H-3/C-4 correlation (Figure 2). The
above data revealed that compound 1 was a monoglyceride
(Figure 1). Thus, the structure was determined to be 2,3-dihy-
droxypropyl 2-methylhexadecanoate.
Effects of fractions and pure compounds on maturation and
activation of DCs
There was no effect of any of the fractions B3b3F–B3b3P on DC
cell viability when compared with the viability of DCs cultured
without fractions or with solvent control (data not shown).
All the fractions decreased secretion of the pro-inflammatory
cytokine IL-12p40 (Figure 3(A)) with the inhibition ranging from
16% to 64% and all fractions, except B3b3K, B3b3M and B3b3N,
decreased DC secretion of the pro-inflammatory cytokine IL-6
with the inhibition ranging from 11% to 25% (Figure 3(B)). The
effects of the fractions on DC secretion of IL-12p40 were more
pronounced than their effects on DC secretion of IL-6. B3b3F
and B3b3J were the only two fractions that affected DC secretion
of the anti-inflammatory cytokine IL-10, both decreasing secre-
tion of IL-10 (Figure 3(C)).
The pure compounds 3-[(1-methoxyhexadecyl)oxy]propane-
1,2-diol (2) (a gift from professor Gudmundur G. Haraldsson at
the Science Institute, University of Iceland), monoheptadecanoin
(3) (Nu-Chek Prep Inc., Waterville, MN), and the one isolated
from B3b3M, 2,3-dihydroxypropyl 2-methylhexadecanoate (1),
did not affect DC secretion of any of the cytokines examined
(data not shown).
To determine whether decreased cytokine secretion by DCs
matured and activated in the presence of fractions B3b3F–B3b3P
was because of unsuccessful maturation and activation of the
DCs, their expression of CD86 and HLA-DR was analyzed.
Maturing and activating the DCs in the presence of fractions
B3b3F-B3b3P did not affect DC expression of these molecules
(data not shown).
The effects of DCs matured in the presence of fractions on
stimulation and differentiation of allogeneic CD41 T cells
Next it was investigated whether, in addition to decreasing DC
secretion of cytokines, the fractions also affected the ability of the
DCs to activate and differentiate CD4þ T cells. Three fractions
were chosen for this analysis, one that effectively decreased both
IL-12p40 and IL-10 secretion by the DCs (B3b3F), one that
effectively decreased DC secretion of IL-12p40 but had less effect
on IL-10 (B3b3J) and one was chosen for comparison as it had
little effect on DC secretion of IL-12p40 and no effect on IL-10
(B3b3P). DCs matured and activated in the presence of all three
fractions decreased T cell secretion of IFN-c, although fractions
B3b3F and B3b3J had more pronounced effect than fraction
B3b3P (Figure 4). The concentration of IL-10 was also decreased
in co-cultures of DCs matured and activated in the presence of
fractions B3b3F and B3b3J and allogeneic CD4þ T cells, but as
IL-10 is produced by both DCs and T cells the cellular source of
the IL-10 could not be determined (Figure 4). Maturation and
activation of DCs in the presence of fractions B3b3F, B3b3J and
B3b3P did not affect the ability of the DCs to induce T cell
secretion of IL-17 (Figure 4).
To determine whether decreased IFN-c secretion by T cells
co-cultured with DCs matured and activated in the presence of
fractions B3b3F or B3b3J was the result of unsuccessful activation
of the allogeneic T cells, the expression of the adhesion molecules
CD54 and CD49d (a-chain of VLA-4) and the early activation
marker CD69 on T cells was analyzed. The expression of these
surface molecules was not affected by co-culture of the T cells
with DCs matured and activated in the presence of fractions
B3b3F or B3b3FJ (data not shown).
Effects of fractions on DC morphology
While screening for anti-inflammatory effects of fractions on
DCs, it was noticed that some of the fractions affected their
morphology. These morphological changes, characterized by
extreme elongation of 1–3 dendrites, were particularly apparent
for DCs matured and activated in the presence of the mother
fraction B3b3 (Figure 5). B3b3 also induced more clustering of
the DCs and at an earlier time-point after maturation and activa-
tion than was observed for DCs matured and activated in the
absence of the fraction (Figure 5). Some of the B3b3 sub-frac-
tions had similar, although less pronounced, effects on the
morphology of the DCs (data not shown).
Discussion
In this study, we show that several lipophilic fractions from the
sponge H. sitiens contain compounds that decrease secretion of
the pro-inflammatory cytokines IL-12p40 and IL-6 by matured
and activated DCs. Only two of the 11 fractions studied
decreased DC secretion of the anti-inflammatory cytokine IL-10
and to a much less extent than that of IL-12p40. The overall
effects of the fractions are, therefore, considered as anti-inflam-
matory. Further examination of the immunomodulatory effects
of three of the fractions revealed that DCs matured and activated
in the presence of fractions B3b3F and B3b3J reduced IFN-c
secretion by co-cultured allogeneic CD4þ T cells by around 50%,
with only a modest reduction in IL-10 secretion, thus decreasing
the ability of the DCs to induce a Th1-type immune response.
The fractions investigated in this study are derived from the
chloroform fraction (B) of the modified Kupchan method, con-
taining mostly glycerol esters and glycerol ethers along with long
chain saturated and unsaturated fatty acids. Most of the fractions
had a number of chemical constituents and no major ones, as
demonstrated by the number of peaks on the HPLC chromato-
grams and mass spectra. As the amount of the material available
Figure 2. Key HMBC (H!C) and 1H-1H COSY (—) correlations of compound 1.
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was limited it was not feasible to subject the fractions to further
isolation. The only fraction that contained one major peak was
B3b3M. The compound isolated from fraction B3b3M is a new
glyceride, 2,3-dihydroxypropyl 2-methylhexadecanoate (1), but it
did not have an immunomodulatory effect on the DCs. Neither
did the two main compounds identified in B3b3J, 3-[(1-methoxy-
hexadecyl)oxy]propane-1,2-diol (2) and monoheptadecanoin (3).
The finding that compounds 2 and 3 did not have immunomo-
dulatory effects was surprising as they were the main constituents
of the fraction (B3b3J) that had the most immunomodulatory
effects of all the fractions examined. Adding the two compounds
in different ratios to the DCs did not affect the cytokine secre-
tion of the DCs. Other constituents in fraction B3b3J, although
in minor quantities, are, therefore, likely to be the ones exerting
the immunomodulatory activity.
Long-chain glycerol esters have been found in marine
sponges, either in the phospholipid fraction or as free derivatives,
and glycerol ethers with different lengths of chains are present in
great amount in shark liver oil (Hallgren and Stallberg 1974).
These have attracted attention of medicinal chemists because of
their structure (Mattson and Volpenhein 1962; Magnusson and
Haraldsson 2010) and potent pharmacological activities, includ-
ing anti-inflammatory activity (Chang et al. 2008; Morin et al.
2011, 2015).
DCs play a crucial role in linking the innate and adaptive
immune systems and polarizing the differentiation of naïve T
cells into appropriate effector phenotypes. DCs are, therefore,
prime targets when evaluating the immunomodulatory effects of
natural compounds. DC secretion of the pro-inflammatory cyto-
kine IL-12 is considered a major contributor to the polarization
of naïve T cells into Th1 effector cells, a phenotype characterized
by secretion of the pro-inflammatory cytokine IFN-c (Manetti
et al. 1994; Macatonia et al. 1995; Gee et al. 2009). The decreased
IL-12p40 secretion by DCs matured in the presence of fractions
B3b3F and B3b3J in the present study was, therefore, expected to
lead to a decrease in their ability to polarize CD4þ T cells into
Th1 effector phenotype, as was evident by the decreased IFN-c
secretion by the CD4þ T cells after co-culture with allogeneic
DCs matured and activated in the presence of fractions B3b3F
and B3b3J. Long-lasting Th1 type immune responses play a role
in the pathogenesis of many inflammatory diseases, such as
Crohn’s disease, type 1 diabetes and rheumatoid arthritis (Zundler
Figure 4. The effects of H. sitiens fractions on the ability of DCs to induce cyto-
kine secretion by allogeneic CD4þ T cells. DCs matured and activated in the
absence (solvent control (CT)) or presence of fractions B3b3F (F), B3b3J (J) and
B3b3P (P) at a concentration of 10mg/mL for 24 h were co-cultured with isolated
allogeneic CD4þ T cells for 6 d and the concentration of IFN-c, IL-17 and IL-10 in
the supernatants determined by ELISA. The data are presented as SI, i.e. the con-
centration of each cytokine in the supernatant of cells treated with fractions div-
ided by the concentration of each cytokine in the supernatant of cells treated
with solvent control. The results are shown as meanþ SEM, n¼ 6. Different from
CT: p< 0.01.
Figure 3. The effects of H. sitiens fractions on DC secretion of IL-12p40, IL-6 and IL-10. DCs were matured and activated by TNF-a, IL-1b and LPS in the absence (solv-
ent control (CT)) or presence of fractions B3b3F–B3b3P (F–P) for 24 h. The supernatants were collected and the concentrations of IL-12p40 (A), IL-6 (B) and IL-10 (C)
were determined by ELISA. The data are presented as SI, i.e. the concentration of each cytokine in the supernatant of cells matured and activated in the presence of
fractions divided by the concentration of the cytokine in the supernatant of cells matured and activated in the absence of fractions. The results are shown as
meanþ SEM, n¼ 6–8. Different from CT: p< 0.05, p< 0.01, p< 0.001.
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and Neurath 2015). Therefore, fractions from H. sitiens that reduce
the Th1-type immune response may contain compounds that could
be evaluated for their effectiveness in such diseases.
In addition to decreasing IL-12p40 secretion by the DCs, the
majority of the fractions examined also decreased DC secretion
of IL-6. IL-6 along with IL-1b is important for differentiation of
naïve T cells into Th17 phenotype, characterized by secretion of
IL-17 (Acosta-Rodriguez et al. 2007). However, although frac-
tions B3b3F, B3b3J and B3b3P reduced DC secretion of IL-6,
none of them affected the concentration of IL-17 in the co-cul-
tures of DCs matured in the presence of the fractions and CD4þ
T cells. As the decrease in IL-6 secretion by DCs matured in the
presence of these fractions was moderate (less than 20%), these
results were not surprising. In addition, others have shown that
decreased IL-6 secretion by DCs cultured in the presence of the
local anaesthetic and cardiac depressant lidocaine did not affect
differentiation of T cells into Th17 cells (Jeon et al. 2015).
Interestingly, as for the H. sitiens fractions B3b3F, B3b3J and
B3b3P in the present study, lidocaine decreased IL-12 secretion
by DCs and inhibited their ability to induce differentiation of
CD4þ T cells into a Th1 phenotype (Jeon et al. 2015).
The fractions B3b3F and B3b3J reduced DC secretion of the
anti-inflammatory cytokine IL-10 as well as the concentration of
IL-10 in the co-culture of DCs and T cells. IL-10 is well estab-
lished as an anti-inflammatory cytokine, exerting multiple effects
in down-regulation and resolution of inflammatory responses
and is a major determinant in differentiation of naïve T cells
into a T regulatory phenotype (Iyer and Cheng 2012). Although
reduction in IL-10 secretion could point towards pro-inflamma-
tory responses, we have observed in previous studies that
decreased IL-10 secretion along with a reduction in IL-12p40
secretion did not hinder the IL-12p40 in reducing IFN-c secre-
tion by co-cultured CD4þ T cells (Freysdottir et al. 2011; Kale
et al. 2013) as was the case in the present study.
The morphological changes of the DCs (elongated dendrites
on the cells) were observed after treatment with fraction B3b3
and some of the B3b3 sub-fractions, but these changes did not
correlate with the immunomodulatory activity of the fractions
nor with their maturation and activation as determined by the
expression of HLA-DR and CD86. The biological significance of
these changes is unknown.
Conclusions
Using bioassay-guided fractionation, several lipophilic fractions
with potent anti-inflammatory effects, i.e., reducing the capacity
of the DCs to secrete IL-12p40 and subsequently to induce Th1-
like response by T cells, were obtained from the sponge H.
sitiens. Although pure compounds were not isolated from these
fractions, it was determined that the majority of the compounds
in these fractions were of glyceride nature. These results highlight
the potential use of lipophilic components from H. sitiens for
immunomodulatory effects.
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